Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Shams NK"'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
Akademický článek
A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6).
Autor: Olander KW; University Eye Specialists, Maryville, TN., Sato MA; East West Eye Institute, Los Angeles, CA., Abrams MA; Abrams Eye Center, Cleveland, OH., Jerkins GW; Advancing Vision Research, Nashville, TN., Lu F; Santen Inc., Emeryville, CA., Dinh P; Santen Inc., Emeryville, CA., Odani-Kawabata N; Santen Inc., Emeryville, CA.; Santen Pharmaceutical Co., Ltd., Osaka, Japan., Chabi A; Santen Inc., Emeryville, CA., Shams NK; Santen Inc., Emeryville, CA.; Santen Pharmaceutical Co., Ltd., Osaka, Japan.
Publikováno v: Journal of glaucoma [J Glaucoma] 2021 Jun 01; Vol. 30 (6), pp. 473-480.
Zobrazit plný text záznamu
3
Akademický článek
Additive Intraocular Pressure-Lowering Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, Combined with Existing Antiglaucoma Agents in Conscious Ocular Normotensive Monkeys.
Autor: Fuwa M; Product Development Division, Santen Pharmaceutical Co., Ltd., Nara, Japan., Shimazaki A; Product Development Division, Santen Pharmaceutical Co., Ltd., Nara, Japan., Odani-Kawabata N; Product Development Division, Santen Pharmaceutical Co., Ltd., Nara, Japan.; Product Development Division, Santen Inc., Emeryville, California, USA., Kirihara T; Ophthalmology Innovation Center, Santen Pharmaceutical Co., Ltd., Osaka, Japan., Taniguchi T; Ophthalmology Innovation Center, Santen Pharmaceutical Co., Ltd., Osaka, Japan., Iwamura R; Pharmaceuticals Research Laboratory, Pharmaceutical Division, Ube Industries, Ltd., Yamaguchi, Japan., Yoneda K; Pharmaceuticals Research Laboratory, Pharmaceutical Division, Ube Industries, Ltd., Yamaguchi, Japan., Kato M; Product Development Division, Santen Pharmaceutical Co., Ltd., Nara, Japan., Morishima K; Product Development Division, Santen Pharmaceutical Co., Ltd., Nara, Japan., Shams NK; Product Development Division, Santen Inc., Emeryville, California, USA.; Ophthalmology Innovation Center, Santen, Inc., Emeryville, California, USA.
Publikováno v: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2021 May; Vol. 37 (4), pp. 223-229. Date of Electronic Publication: 2021 Feb 17.
Zobrazit plný text záznamu
4
Akademický článek
Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study.
Autor: Aihara M; Department of Ophthalmology, University of Tokyo, Bunkyo-ku, Tokyo, Japan., Lu F; Santen Inc., Emeryville, California, USA. Electronic address: fenghe_lu@hotmail.com., Kawata H; Santen Pharmaceutical Co. Ltd., Osaka, Japan., Iwata A; Santen Inc., Emeryville, California, USA; Santen Pharmaceutical Co. Ltd., Osaka, Japan., Odani-Kawabata N; Santen Inc., Emeryville, California, USA; Santen Pharmaceutical Co. Ltd., Osaka, Japan., Shams NK; Santen Inc., Emeryville, California, USA; Santen Pharmaceutical Co. Ltd., Osaka, Japan.
Publikováno v: American journal of ophthalmology [Am J Ophthalmol] 2020 Dec; Vol. 220, pp. 53-63. Date of Electronic Publication: 2020 Jun 10.
Zobrazit plný text záznamu
5
Akademický článek
The Antiglaucoma Agent and EP2 Receptor Agonist Omidenepag Does Not Affect Eyelash Growth in Mice.
Autor: Esaki Y; Santen Pharmaceutical Co., Ltd., Research and Development Division, Nara, Japan., Katsuta O; Santen Pharmaceutical Co., Ltd., Research and Development Division, Nara, Japan., Kamio H; Santen Pharmaceutical Co., Ltd., Research and Development Division, Nara, Japan., Noto T; Santen Pharmaceutical Co., Ltd., Research and Development Division, Nara, Japan., Mano H; Santen Pharmaceutical Co., Ltd., Research and Development Division, Nara, Japan., Iwamura R; Ube Industries, Ltd., Pharmaceuticals Research Laboratory, Pharmaceutical Division, Yamaguchi, Japan., Yoneda K; Ube Industries, Ltd., Pharmaceuticals Research Laboratory, Pharmaceutical Division, Yamaguchi, Japan., Odani-Kawabata N; Santen Pharmaceutical Co., Ltd., Osaka, Japan.; Santen, Inc., Research and Development Division, Emeryville, California, USA., Morishima K; Santen Pharmaceutical Co., Ltd., Research and Development Division, Nara, Japan., Shams NK; Santen, Inc., Research and Development Division, Emeryville, California, USA.
Publikováno v: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2020 Sep; Vol. 36 (7), pp. 529-533. Date of Electronic Publication: 2020 May 17.
Zobrazit plný text záznamu
6
Akademický článek
Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells.
Autor: Yamamoto Y; Research and Development Division, Santen Pharmaceutical Co., Ltd., Nara, Japan., Taniguchi T; Research and Development Division, Santen Pharmaceutical Co., Ltd., Nara, Japan., Inazumi T; Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Iwamura R; Pharmaceuticals Research Laboratory, Pharmaceutical Division, Ube Industries, Ltd., Yamaguchi, Japan., Yoneda K; Pharmaceuticals Research Laboratory, Pharmaceutical Division, Ube Industries, Ltd., Yamaguchi, Japan., Odani-Kawabata N; Research and Development Division, Santen Pharmaceutical Co., Ltd., Osaka, Japan.; Research and Development Division, Santen, Inc., Emeryville, California., Matsugi T; Research and Development Division, Santen Pharmaceutical Co., Ltd., Nara, Japan., Sugimoto Y; Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Shams NK; Research and Development Division, Santen, Inc., Emeryville, California.
Publikováno v: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2020 Apr; Vol. 36 (3), pp. 162-169. Date of Electronic Publication: 2020 Jan 14.
Zobrazit plný text záznamu
7
Akademický článek
Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study).
Autor: Aihara M; Department of Ophthalmology, University of Tokyo, Bunkyo-ku, Japan., Lu F; Santen, Inc., Emeryville, California., Kawata H; Santen Pharmaceutical Co., Ltd., Osaka, Japan., Tanaka Y; Santen Pharmaceutical Co., Ltd., Osaka, Japan., Yamamura K; Santen Pharmaceutical Co., Ltd., Ikoma, Japan., Odani-Kawabata N; Santen, Inc., Emeryville, California.; Santen Pharmaceutical Co., Ltd., Osaka, Japan., Shams NK; Santen, Inc., Emeryville, California.; Santen Pharmaceutical Co., Ltd., Osaka, Japan.
Publikováno v: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2019 Dec; Vol. 35 (10), pp. 542-550. Date of Electronic Publication: 2019 Nov 01.
Zobrazit plný text záznamu
8
Akademický článek
Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension.
Autor: Aihara M; Ophthalmology, University of Tokyo, Bunkyo-ku., Lu F; Santen Inc., Emeryville, CA., Kawata H; Santen Pharmaceutical Co., Ltd., Osaka, Japan., Iwata A; Santen Pharmaceutical Co., Ltd., Osaka, Japan., Liu K; Santen Inc., Emeryville, CA., Odani-Kawabata N; Santen Inc., Emeryville, CA.; Santen Pharmaceutical Co., Ltd., Osaka, Japan., Shams NK; Santen Inc., Emeryville, CA.; Santen Pharmaceutical Co., Ltd., Osaka, Japan.
Publikováno v: Journal of glaucoma [J Glaucoma] 2019 May; Vol. 28 (5), pp. 375-385.
Zobrazit plný text záznamu
9
Akademický článek
Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys.
Autor: Fuwa M; 1 R&D Division, Santen Pharmaceutical Co., Ltd. , Nara, Japan ., Toris CB; 2 Department of Ophthalmology, Nebraska Medical Center, University of Nebraska Medical Center , Omaha, Nebraska.; 3 Department of Ophthalmology, Case Western Reserve University , Cleveland, Ohio., Fan S; 2 Department of Ophthalmology, Nebraska Medical Center, University of Nebraska Medical Center , Omaha, Nebraska., Taniguchi T; 1 R&D Division, Santen Pharmaceutical Co., Ltd. , Nara, Japan ., Ichikawa M; 1 R&D Division, Santen Pharmaceutical Co., Ltd. , Nara, Japan ., Odani-Kawabata N; 4 R&D Division, Santen Pharmaceutical Co., Ltd. , Osaka, Japan ., Iwamura R; 5 Pharmaceuticals Research Laboratory, Pharmaceutical Division, Ube Industries, Ltd. , Yamaguchi, Japan ., Yoneda K; 5 Pharmaceuticals Research Laboratory, Pharmaceutical Division, Ube Industries, Ltd. , Yamaguchi, Japan ., Matsugi T; 1 R&D Division, Santen Pharmaceutical Co., Ltd. , Nara, Japan ., Shams NK; 4 R&D Division, Santen Pharmaceutical Co., Ltd. , Osaka, Japan .; 6 R&D Division, Santen, Inc. , Emeryville, California., Zhang JZ; 1 R&D Division, Santen Pharmaceutical Co., Ltd. , Nara, Japan .; 6 R&D Division, Santen, Inc. , Emeryville, California.
Publikováno v: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2018 Sep; Vol. 34 (7), pp. 531-537. Date of Electronic Publication: 2018 Jul 10.
Zobrazit plný text záznamu
10
Akademický článek
Cholylglycine measured in serum by RIA and interleukin-1 beta determined by ELISA in differentiating viral hepatitis from chemical liver injury.
Autor: Li GY; Occupational Safety and Health Institute of Chemical Industrial Ministry Qingdao, China., Wang T, Huggins EM Jr, Shams NK, Davis JF, Calkins JH, Hornung CA, Altekruse JM, Sigel MM
Publikováno v: Journal of occupational medicine. : official publication of the Industrial Medical Association [J Occup Med] 1992 Sep; Vol. 34 (9), pp. 930-3.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje